{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:13:05Z","timestamp":1777425185180,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1124\/jpet.120.264952","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T22:45:12Z","timestamp":1586385912000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of the Reinforcing Strength of Phendimetrazine Using a Progressive-Ratio Schedule of Reinforcement in Rhesus Monkeys"],"prefix":"10.1016","volume":"374","author":[{"given":"Molly","family":"Minkiewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul W.","family":"Czoty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce E.","family":"Blough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Nader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.264952_bib1","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1080\/14656566.2016.1244529","article-title":"Update on pharmacotherapy for treatment of opioid use disorder","volume":"17","author":"Ayanga","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"10.1124\/jpet.120.264952_bib2","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1038\/npp.2013.180","article-title":"Effects of phendimetrazine treatment on cocaine vs food choice and extended-access cocaine consumption in rhesus monkeys","volume":"38","author":"Banks","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.120.264952_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2012.10.026","article-title":"Role of phenmetrazine as an active metabolite of phendimetrazine: evidence from studies of drug discrimination and pharmacokinetics in rhesus monkeys","volume":"130","author":"Banks","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.120.264952_bib4","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/FBP.0b013e32834d63ac","article-title":"Effects of monoamine releasers with varying selectivity for releasing dopamine\/norepinephrine versus serotonin on choice between cocaine and food in rhesus monkeys","volume":"22","author":"Banks","year":"2011","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.120.264952_bib5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.drugalcdep.2013.05.005","article-title":"Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys","volume":"131","author":"Banks","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.120.264952_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/npp.2012.193","article-title":"Interaction between behavioral and pharmacological treatment strategies to decrease cocaine choice in rhesus monkeys","volume":"38","author":"Banks","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.120.264952_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pbb.2015.12.001","article-title":"Relationship between discriminative stimulus effects and plasma methamphetamine and amphetamine levels of intramuscular methamphetamine in male rhesus monkeys","volume":"141","author":"Banks","year":"2016","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.120.264952_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/ADM.0000000000000206","article-title":"Abuse potential of oral phendimetrazine in cocaine-dependent individuals: implications for agonist-like replacement therapy","volume":"10","author":"Bolin","year":"2016","journal-title":"J Addict Med"},{"key":"10.1124\/jpet.120.264952_bib9","first-page":"CD009329","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","volume":"34","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/jpet.120.264952_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00213-009-1622-4","article-title":"Decreased reinforcing effects of cocaine following 2 weeks of continuous D-amphetamine treatment in rats","volume":"206","author":"Chiodo","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.120.264952_bib11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1124\/jpet.107.123042","article-title":"Drug and reinforcement history as determinants of the response-maintaining effects of quinpirole in the rat","volume":"323","author":"Collins","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.264952_bib12","first-page":"351","article-title":"Anorectics: effects on food intake and self-administration in rhesus monkeys","volume":"7","author":"Corwin","year":"1987","journal-title":"Alcohol Drug Res"},{"key":"10.1124\/jpet.120.264952_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuroscience.2016.03.002","article-title":"Attenuation of cocaine self-administration by chronic oral phendimetrazine in rhesus monkeys","volume":"324","author":"Czoty","year":"2016","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.120.264952_bib14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/npp.2010.185","article-title":"Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys","volume":"36","author":"Czoty","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.120.264952_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-010-1807-x","article-title":"Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys","volume":"209","author":"Czoty","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.120.264952_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/pr.115.011668","article-title":"Evaluation of the \u201cpipeline\u201d for development of medications for cocaine use disorder: a review of translational preclinical, human laboratory, and clinical trial research","volume":"68","author":"Czoty","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.120.264952_bib17","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00213-015-3875-4","article-title":"Effects of the dopamine\/norepinephrine releaser phenmetrazine on cocaine self-administration and cocaine-primed reinstatement in rats","volume":"232","author":"Czoty","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.120.264952_bib18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","article-title":"Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial","volume":"21","author":"Grabowski","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/jpet.120.264952_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/B978-0-12-004702-4.50010-2","article-title":"Predicting the abuse liability of drugs with self-administration procedures: psychomotor stimulants and hallucinogens","volume":"2","author":"Griffiths","year":"1979","journal-title":"Adv Behav Pharmacol"},{"key":"10.1124\/jpet.120.264952_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1749-6632.2009.05145.x","article-title":"Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies","volume":"1187","author":"Herin","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.120.264952_bib21","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1124\/pr.110.003459","article-title":"Prodrugs--from serendipity to rational design","volume":"63","author":"Huttunen","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.120.264952_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00008877-199000140-00003","article-title":"Models of relative reinforcing efficacy of drugs and their predictive utility","volume":"1","author":"Katz","year":"1990","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.120.264952_bib23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1185\/030079908X280707","article-title":"A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders","volume":"24","author":"Kollins","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1124\/jpet.120.264952_bib24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1037\/1064-1297.8.3.424","article-title":"First- versus last-session substitution: an evaluation of the reinforcing effects of cocaine and the cocaine analogue 2beta-propanoyl-3beta-(4-tolyl)-tropane","volume":"8","author":"Lile","year":"2000","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.120.264952_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.pbr.2015.07.012","article-title":"Animal models for addiction medicine: from vulnerable phenotypes to addicted individuals","volume":"224","author":"Nader","year":"2016","journal-title":"Prog Brain Res"},{"key":"10.1124\/jpet.120.264952_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02247388","article-title":"Self-administration of the dopamine D3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure","volume":"125","author":"Nader","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.120.264952_bib27","doi-asserted-by":"crossref","first-page":"a012104","DOI":"10.1101\/cshperspect.a012104","article-title":"Medications development for opioid abuse","volume":"3","author":"Negus","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1124\/jpet.120.264952_bib28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1124\/jpet.108.143701","article-title":"Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine","volume":"329","author":"Negus","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.264952_bib29","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/npp.2014.322","article-title":"Agonist medications for the treatment of cocaine use disorder","volume":"40","author":"Negus","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.120.264952_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(02)00339-3","article-title":"Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys","volume":"70","author":"Negus","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.120.264952_bib31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/NDT.S9749","article-title":"Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine","volume":"6","author":"Pennick","year":"2010","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1124\/jpet.120.264952_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","article-title":"Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy","volume":"66","author":"Richardson","year":"1996","journal-title":"J Neurosci Methods"},{"key":"10.1124\/jpet.120.264952_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(02)01830-7","article-title":"Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain","volume":"447","author":"Rothman","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.120.264952_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4155\/fmc.11.184","article-title":"Agonist replacement therapy for cocaine dependence: a translational review","volume":"4","author":"Rush","year":"2012","journal-title":"Future Med Chem"},{"key":"10.1124\/jpet.120.264952_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2008.08.009","article-title":"Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy","volume":"99","author":"Rush","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.120.264952_bib36","doi-asserted-by":"crossref","first-page":"31385","DOI":"10.1038\/srep31385","article-title":"Dissociable effects of the prodrug phendimetrazine and its metabolite phenmetrazine at dopamine transporters","volume":"6","author":"Solis","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.120.264952_bib37","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s00213-019-05227-x","article-title":"Influence of phendimetrazine maintenance on the reinforcing, subjective, performance, and physiological effects of intranasal cocaine","volume":"236","author":"Stoops","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.120.264952_bib38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2015.07.046","article-title":"The brain on drugs: from reward to addiction","volume":"162","author":"Volkow","year":"2015","journal-title":"Cell"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524257827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524257827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.264952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:54:24Z","timestamp":1739973264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524257827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0022356524257827"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.264952","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Reinforcing Strength of Phendimetrazine Using a Progressive-Ratio Schedule of Reinforcement in Rhesus Monkeys","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.264952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}